Clinical Trial Update: Effect of ZaStaprazan on Platelet Reactivity of Clopidogrel After PercuTaneous CoronAry InteRvention [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating ZaStaprazan's effect on platelet reactivity to Clopidogrel after PCI in chronic coronary syndrome; recruitment is ongoi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• ZaStaprazan (ZaStaprazan)

Snippet

Sponsor: Yonsei University | Conditions: Chronic Coronary Syndrome | Phase 4 | Status: RECRUITING